Complete Longitudinal Analyses of the Randomized, Placebo-Controlled, Phase III Trial of Sunitinib in Patients with Gastrointestinal Stromal Tumor following Imatinib Failure-Reference-Cited by-同舟云学术

Complete Longitudinal Analyses of the Randomized, Placebo-Controlled, Phase III Trial of Sunitinib in Patients with Gastrointestinal Stromal Tumor following Imatinib Failure

Published:2012-05-31 Issue:11 Volume:18 Page:3170-3179
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Demetri George D.,Garrett Christopher R.,Schöffski Patrick,Shah Manisha H.,Verweij Jaap,Leyvraz Serge,Hurwitz Herbert I.,Pousa Antonio Lopez,Le Cesne Axel,Goldstein David,Paz-Ares Luis,Blay Jean-Yves,McArthur Grant A.,Xu Qiang (Casey),Huang Xin,Harmon Charles S.,Tassell Vanessa,Cohen Darrel P.,Casali Paolo G.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sunitinib for the treatment of metastatic gastrointestinal stromal tumors: the effect of TDM-guided dose optimization on clinical outcomes;ESMO Open;2024-06

2. English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology;International Journal of Clinical Oncology;2024-04-13

3. Treatment Access for Gastrointestinal Stromal Tumor in Predominantly Low- and Middle-Income Countries;JAMA Network Open;2024-04-03

4. Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007–001 Studies;Clinical Cancer Research;2024-01-05

5. Pan-Canadian consensus recommendations for GIST management in high- and low-throughput centres across Canada;Therapeutic Advances in Medical Oncology;2024-01